- Lobbying
- Lobbying by Illumina, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Holly Fechner | Policy Director, Senator Edward M. Kennedy; Chief Labor & Pensions Counsel, Senate HELP Committee Policy Director, Senate HELP Committee |
Muftiah McCartin | House Rules Committee, Staff Director; House Rules Committee, Deputy Staff Director; House Select Committee on Voting Registration Irregularities, General Counsel, detailed (9/2007-9/2008) House Rules Cmte. - Staff Director; Deputy Staff Director |
Layth Elhassani | WH Office of Leg. Affairs, Spec. Asst. to the President; Senator Michael F. Bennet, Leg. Dir.; House Comm. on Small Business, Oversight Counsel; Rep. Nydia Velazquez, Leg. Dir.; Sen. Maria Cantwell, Leg. Counsel; Sen. Hollings, Legal Counsel |
Gary Heimberg | n/a |
Richard Hertling | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Office of the Vice President of the United States
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Office of the Vice President of the United States
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Office of the Vice President of the United States
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to precision medicine, laboratory developed tests and next generation sequencing.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate